| Literature DB >> 26928196 |
David B Bartlett1, Oliver Fox2, Clare L McNulty3, Hannah L Greenwood2, Laura Murphy2, Elizabeth Sapey2, Martin Goodman4, Nicola Crabtree5, Cecilie Thøgersen-Ntoumani3, James P Fisher3, Anton J M Wagenmakers6, Janet M Lord2.
Abstract
BACKGROUND: Dysfunctional neutrophils with advanced age are a hallmark of immunosenescence. Reduced migration and bactericidal activity increase the risk of infection. It remains unclear why neutrophil dysfunction occurs with age. Physical activity and structured exercise have been suggested to improve immune function in the elderly. The aim of this study was to assess a comprehensive range of neutrophil functions and determine their association with habitual physical activity.Entities:
Keywords: Ageing; Immunosenescence; Inflammation; Innate immunity; Migration; Neutrophil; Physical activity
Mesh:
Year: 2016 PMID: 26928196 PMCID: PMC4929133 DOI: 10.1016/j.bbi.2016.02.024
Source DB: PubMed Journal: Brain Behav Immun ISSN: 0889-1591 Impact factor: 7.217
Characteristics of the forty older participants assessed.
| Elderly activity group | ||
|---|---|---|
| Most active (MA) | Least active (LA) | |
| Gender (M/F) | 10/10 | 10/10 |
| Age (years) | 67.4 ± 5.0 | 66.6 ± 4.9 |
| Steps (per day) | 10370 ± 3221 | 4746 ± 1351∗∗∗ |
| IPAQ (AU) | 29.4 ± 16.9 | 13.4 ± 11.3∗ |
| Grip Strength (kg) | 30 ± 9 | 32 ± 9 |
| Berg Balance Score (AU) | 55.2 ± 1.4 | 55.3 ± 1.1 |
| Timed-up-and-go (seconds) | 8.1 ± 1.5 | 8.4 ± 1.4 |
| BMI (kg/m2) | 23.5 ± 3.1 | 26.7 ± 3.9∗∗ |
| Body Fat (%) | 26.2 ± 7.9 | 31.5 ± 6.7∗ |
| Blood Pressure | ||
| Systolic (mmHg) | 128 ± 16 | 127 ± 13 |
| Diastolic (mmHg) | 77 ± 6 | 77 ± 7 |
| Resting Heart Rate (bpm) | 65 ± 9 | 64 ± 8 |
| Current Smoker (Y/N) | 0/20 | 2/18 |
| Use of Statins (Y/N) | 1/19 | 5/15 |
| White Blood Cells | ||
| Neutrophils (109/L) | 3.08 ± 0.8 | 3.34 ± 0.8 |
| Monocytes (109/L) | 0.27 ± 0.08 | 0.32 ± 0.12 |
| Lymphocytes (109/L) | 1.28 ± 0.28 | 2.00 ± 1.64 |
| Fasting Glucose (mmol/L) | 5.0 ± 0.4 | 5.4 ± 0.5∗ |
| Fasting Insulin (μIU/ml) | 12.3 ± 4.1 | 20.9 ± 11.5∗∗ |
| HOMA-IR (AU) | 2.8 ± 1.1 | 5.1 ± 3.2∗∗ |
| Triglycerides (mmol/L) | 1.14 ± 0.56 | 1.16 ± 0.62 |
| Cholesterol [statin+ (mmol/L)] | 5.80 | 4.15 ± 0.47 |
| Cholesterol [statin− (mmol/L)] | 5.75 ± 0.97 | 5.04 ± 1.34 |
| Leptin (ng/ml) | 9.9 ± 7.8 | 15.7 ± 8.7∗ |
| Adiponectin (μg/ml) | 4.2 ± 2.0 | 3.1 ± 1.1∗ |
| Leptin: Adiponectin Ratio | 2.5 ± 1.9 | 5.5 ± 3.7∗∗ |
IPAQ (International Physical Activity Questionnaire); AU (Arbitrary Units); BMI (Body Mass Index); HOMA-IR (Homeostasis Model Assessment for Insulin Resistance); Statin+ (Prescribed statins); Statin- (Not prescribed statins). Data are mean ± SD unless indicated otherwise. *p < 0.05, **p < 0.01, ***p < 0.001 compared to MA.
Fig. 1Differences for neutrophil chemotaxis (A), chemokinesis (B) and chemotactic index (C) for cells isolated from Young (n = 10), Most active (MA) and Least active (LA) older participants (n = 20 each). Data are mean ± SEM.
Fig. 2Correlation analyses plus 95% confidence intervals of metabolic variables for all older participants (n = 40) and their relationship with Chemotactic Index for Adiponectin (A), Leptin (B), Glucose (C), and Insulin (D).
Fig. 3Differences between the Young, Most (MA) and Least Active (LA) older participants for neutrophil uptake of FITC-labelled E. coli (A) and the oxidative burst against ingested E. coli (B). Data are mean ± SEM.
Surface receptor expression (MFI) of key mediators of neutrophil adhesion and migration between young (n = 10) and older participants (n = 40). Data are mean ± SEM.
| Young | Old | |||
|---|---|---|---|---|
| All | MA | LA | ||
| CXCR1 | 55.1 ± 2.8 | 58.3 ± 1.5 | 57.3 ± 2.5 | 59.3 ± 1.6 |
| CXCR2 | 61.9 ± 12.2 | 47.4 ± 4.2 | 53.5 ± 6.3 | 41.6 ± 5.4 |
| CD11b | 26.6 ± 4.5 | 19.8 ± 2.3 | 25.2 ± 4.2 | 14.6 ± 1.6∗# |
| CD18 | 39.3 ± 5.3 | 40.2 ± 3.7 | 45.6 ± 5.9 | 35.1 ± 4.3 |
CXCR (CXC Chemokine Receptor); CD (Cluster of Differentiation). *p < 0.05 and #p < 0.05 compared to MA and young respectively
Concentrations of pro- and anti-inflammatory mediators between the young (n = 10) and older (n = 40) participants. Values are pg/ml unless stated otherwise and data are mean ± SEM.
| Young | Old | |||
|---|---|---|---|---|
| All | MA (n = 20) | LA (n = 20) | ||
| IL-1β (pg/ml)a | 0.21 ± 0.05 | 0.33 ± 0.04 | 0.31 ± 0.05 | 0.35 ± 0.07 |
| IL-6 (pg/ml)a | 1.36 ± 0.92 | 5.11 ± 1.49# | 5.71 ± 2.27 | 4.46 ± 1.99 |
| IL-8 (pg/ml) | 5.63 ± 0.58 | 6.79 ± 0.30# | 6.49 ± 0.32 | 7.11 ± 0.51 |
| IL-17 (pg/ml)a | 10.09 ± 10.09 | 16.01 ± 6.55 | 17.40 ± 11.33 | 14.48 ± 6.13 |
| TNFα (pg/ml)a | 0.23 ± 0.11 | 3.99 ± 2.47 | 5.36 ± 4.40 | 2.48 ± 1.96 |
| CRP (mg/L)a | 1.30 ± 0.81 | 2.13 ± 0.45# | 2.46 ± 0.81 | 1.77 ± 0.29 |
| GM-CSF (pg/ml)a | ND | 2.13 ± 1.52 | 2.44 ± 2.44 | 1.79 ± 1.79 |
| MCP-1 (pg/ml) | 27.63 ± 2.44 | 43.84 ± 2.57## | 43.31 ± 3.84# | 44.42 ± 3.44# |
| IL-4 (pg/ml)a | ND | 0.01 ± 0.01 | 0.02 ± 0.01 | 0.01 ± 0.01 |
| IL-10 (pg/ml)a | 7.12 ± 3.12 | 19.34 ± 3.45## | 17.33 ± 4.67 | 21.56 ± 5.19# |
| IL-13 (pg/ml) | 4.13 ± 1.20 | 7.15 ± 0.71# | 6.29 ± 0.87 | 8.10 ± 1.14 |
ND (not-detectable); IL (Interleukin); TNFα (tumour necrosis factor-α); CRP (C-Reactive Protein); GM-CSF (Granulocyte/Monocyte Colony Stimulating Factor); MCP-1 (Monocyte Chemoattractant Protein-1). aNot normally distributed and log-transformed. #p < 0.05 and ##p < 0.01 compared to young group.